NAPSA branches unite to campaign for Prac Payments, new research on peanut allergies, promising sepsis drug trial, new cancer survivors’ centre, PBS listing, and more
Click here to download Pharmacy Daily for Monday 13th May 2024
NAPSA branches unite to campaign for Prac Payments, new research on peanut allergies, promising sepsis drug trial, new cancer survivors’ centre, PBS listing, and more
Click here to download Pharmacy Daily for Monday 13th May 2024
SIGMA Healthcare Limited’s share price has surged this week, reaching $2.06, up from $1.46 seven days ago.
JARDIANCE (empagliflozin) has become the first oral treatment to be available on private script for type 2 diabetes (T2D) in children and adolescents, since metformin was indicated for use in this growing patient group.
PRICELINE is set to undergo a rebrand next month to reflect its strategy combining beauty with health expertise and value.
FREE Pharmacy Daily subscription - never miss another story!
Pharmacy Daily subscription confirmation
Thank you for signing up! Check your email inbox – you should shortly receive a message with a link which must be clicked to confirm your subscription.
Once you’ve done that you will begin receiving Pharmacy Daily as soon as the next issue is published.